-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Kodiak Sciences Inc. (KOD)
-
-
-
-
-
-
-
Kodiak reports positive 20-week data for macular edema treatment KSI-101
-
-
-
-
-
-
-
Kodiak Sciences Inc. (KOD) Tops Q2 EPS by 1c
-
-
-
-
-
-
-
Goldman Sachs Reiterates Sell Rating on Kodiak Sciences Inc. (KOD)
-
-
456,387 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

